Piper Sandler initiated coverage on VectivBio with a new price target

7/1/22 7:43:59 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Piper Sandler initiated coverage of VectivBio with a rating of Overweight and set a new price target of $23.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$VECT

Date	Price Target	Rating	Analyst
12/13/2022	$18.00	Buy	Jefferies
7/1/2022	$23.00	Overweight	Piper Sandler